Non-ergot dopamine agonist-induced sleep attacks

被引：36

作者：

Ryan, M

Slevin, JT

Wells, A

机构：

[1] Univ Kentucky, Med Ctr, Div Pharm Practice & Sci, Coll Pharm, Lexington, KY 40536 USA

[2] Univ Kentucky, Coll Med, Dept Neurol, Lexington, KY 40536 USA

[3] Dept Vet Affairs, Lexington, KY USA

来源：

PHARMACOTHERAPY | 2000年 / 20卷 / 06期

关键词：

D O I：

10.1592/phco.20.7.724.35181

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non-ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life-threatening adverse effect.

引用

页码：724 / 726

页数：3

共 8 条

[1] Disorders of excessive daytime sleepiness - an update
El-Ad, B
Korczyn, AD
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 153 (02) : 192 - 202
[2] Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
Frucht, S
Rogers, JD
Greene, PE
Gordon, MF
Fahn, S
[J]. NEUROLOGY, 1999, 52 (09) : 1908 - 1910
[3] Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats
Lagos, P
Scorza, C
Monti, JM
Jantos, H
Reyes-Parada, M
Silveira, R
Ponzoni, A
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1998, 8 (02) : 113 - 120
[4] Olanow CW, 2000, MOVEMENT DISORD, V15, P212, DOI 10.1002/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO
[5] 2-6
[6] An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
Olanow, CW
Koller, WC
[J]. NEUROLOGY, 1998, 50 (03) : S1 - S57
[7] Olanow CW, 2000, NEUROLOGY, V54, P274, DOI 10.1212/WNL.54.1.274
[8] Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors
Perachon, S
Schwartz, JC
Sokoloff, P
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (2-3) : 293 - 300

← 1 →